Dualitas Therapeutics
San Francisco
About Dualitas Therapeutics
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders and other conditions. With a growing collection of innovative cell surface proximity engagers and our in-house DualScreen™ discovery engine, our pipeline
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 11 – 50
- Total funding: $65.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: dualitastx.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/dualitas-therapeutics-104873 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.